The present work was focused on the development of pluronic based ibuprofen gels for the purpose of increasing drug solubility with the aid of pluronic F127, pluronic L64, and propylene glycol additives as gelling agents and central composite design (CCD) expert software for optimizing their percentage content. The desired gels were formulated and evaluated for the gelation temperature and drug content as analyzed by the CCD expert software. Finally optimized gel formulations (OFs) were subjected to in vitro diffusion studies in terms of a kinetic fitting model. It was found that OF1 had the optimum concentrations in making effective pluronic based ibuprofen gels with desired response characteristics. Pluronic gels can be used as efficient means of formulation to enhance drug solubility and permeability which is confirmed by the results of in vitro diffusion studies and flux calculations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
B. W. Barry, Transdermal Drug Delivery, in: M. E. Aulton (Ed.), Aulton’s Pharmaceutics: The Design and Manufacture of Medicines, Elsevier (2007), pp. 565 – 597.
K. Savalesager, Asian J. Res. Biol. Pharm. Sci., 3(4), 150 – 161 (2015).
Encyclopedia of Pharmaceutical Technology, 3rd Edn., CRC Press (2006), Vol. 3, pp. 1875 – 1890.
Loveleen Preet Kaur, Rajeev Garg, and G. D. Gupta, Topical Gels: A Review, Res. J. Pharm. Technol., 3 (1), (2010).
B. Sujitha and B. Krishnamoorthy, Int. J. Adv. Pharm. Gen. Res., 2(1), 34 – 45 (2014).
A. H. El-Kamel, Int. J. Pharm., 241(1), 47 – 55, (2002).
S. B. Hoffman, A. R. Yoder and L. A. Trepanier. J. Vet. Pharmacol. Ther., 25(3), 189 – 93, (2002).
Y. Yuan, Y. Cui, L. Zhang, et al., Int. J. Pharm., 430(1 – 2), 114 – 119, (2012).
E. Gioffredi, M. Boffito, S. Calzone, et al., Proc. CIRP, 49, 125 – 132 (2016)
M. S. Akash, K. Rehman, N. Li, et al., Pharm. Res., 29(12), 3475 – 3485 (2012).
K. D. Rainsford. Int. J. Clin. Pract. Suppl., 135, 3 – 8 (2003).
G. M. Halford, M. Lordkipanidze, and S. P. Watson. Platelets, 23(6), 415 – 422, (2012).
R. Bushra and N. Aslam. Oman Med. J. 25(3), 155 – 166, (2010).
S. S .Adams, K. F. McCullough, and J. S. Nicholson. Arch. Int. Pharmacodyn. Ther., 178(1), 115 – 129 (1969).
K. Vijay, D. Marja, L. La, et al., Indian J. Pharm. Sci., 235, 129 – 140 (2002).
Indian Pharmacopoeia, 5th Edn. (2007).
E. Baloglu, S. Y. Karavana, Z. A. Senyigit, et al., J. Pharm. Pharmacol., 63(10), 1274 – 1282 (2011).
G. Dumortier, J. Grossiord, F. Agnely, et al., Pharm. Res. 23(12), 2709 – 2728 (2006).
E. Baloglu, S. Y. Karavana, Z. A. Senyigit, et al., Pharm. Dev. Technol., 16(6), 627 – 636 (2011).
L. Kumar and R. Verma. Int. J. Drug Deliv., 2(1), (2010).
P. Peneva, V. Andonova, T. Dimcheva, et al., Indian J. Pharm. Educ. Res. 52(2), 212 – 217 (2018).
P. Costa and J. M. Lobo, Eur. J. Pharm. Sci., 13(2), 123 – 133 (2001).
A. Harani, S. K. Dinakaran, R. Kakaraparthy, et al., Drug Dev. Ind. Pharm, 1 – 37 (2019).
H. K. Shaikh, R. V. Kshirsagar, and S. G. Patil, World J. Pharm. Pharm. Sci, 4(4), 324 – 338 (2015).
A. C. Salome, C. O. Godswill, and I. O. Ikechukwu, Res. J. Pharm. Biol. Chem. Sci.. 4(2), 97 – 103 (2013).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Avasarala, H., Kumar, D.S., Tripathy, S. et al. Design and Statistical Optimization of Pluronic Based Ibuprofen Gels by Box-Behnken Design and Their Physicochemical Characterization. Pharm Chem J 57, 129–137 (2023). https://doi.org/10.1007/s11094-023-02860-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02860-x